PDL BioPharma, Inc. Operating CF/Net income

Operating CF/Net income of PDLI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Operating CF/Net income growth rates and interactive chart. Calculated as operating cash flow divided by net income to common shareholders. Also called income quality ratio. A ratio of greater than 1.0 usually indicates high-quality income, while a ratio of less than 1.0 indicates low-quality.


Highlights and Quick Summary

  • Operating CF/Net income for the quarter ending June 29, 2020 was 0.4 (a -15.91% decrease compared to previous quarter)
  • Year-over-year quarterly Operating CF/Net income decreased by -78.84%
  • Annual Operating CF/Net income for 2019 was 0.46 (a 136.31% increase from previous year)
  • Annual Operating CF/Net income for 2018 was 0.2 (a -46.84% decrease from previous year)
  • Annual Operating CF/Net income for 2017 was 0.37 (a -77.06% decrease from previous year)
  • Twelve month Operating CF/Net income ending June 29, 2020 was 0.57 (a 37.56% increase compared to previous quarter)
  • Twelve month trailing Operating CF/Net income decreased by -102.82% year-over-year
Trailing Operating CF/Net income for the last four month:
29 Jun '20 30 Mar '20 30 Dec '19 29 Sep '19
0.57 0.42 0.46 -20.32
Visit stockrow.com/PDLI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Operating CF/Net income of PDL BioPharma, Inc.

Most recent Operating CF/Net incomeof PDLI including historical data for past 10 years.

Interactive Chart of Operating CF/Net income of PDL BioPharma, Inc.

PDL BioPharma, Inc. Operating CF/Net income for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 0.4 0.48
2019 0.35 1.91 -5.2 -0.34 0.46
2018 -0.13 0.33 0.06 -8.44 0.2
2017 -0.78 -0.17 0.26 6.32 0.37
2016 -1.51 -0.62 0.54 1.66 1.6
2015 0.7 1.09 1.07 0.85 0.91
2014 1.25 0.75 0.85 0.93 0.91
2013 1.0 0.82 1.17 0.99 1.02
2012 1.09 0.74 1.43 0.45 1.0
2011 1.16 0.8 1.44 -0.3 0.85
2010 -1.23 0.76 1.93 2.01

Business Profile of PDL BioPharma, Inc.

Sector: Other
Industry: Other
PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.